 Adenosine Monophosphate
"Adenosine Monophosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
| Descriptor ID |
D000249
|
| MeSH Number(s) |
D03.633.100.759.646.138.180 D13.695.667.138.180 D13.695.827.068.180
|
| Concept/Terms |
2'-Adenylic Acid- 2'-Adenylic Acid
- 2' Adenylic Acid
- Acid, 2'-Adenylic
- 2'-Adenosine Monophosphate
- 2' Adenosine Monophosphate
- Monophosphate, 2'-Adenosine
- Adenylic Acid
- 2'-AMP
|
Below are MeSH descriptors whose meaning is more general than "Adenosine Monophosphate".
Below are MeSH descriptors whose meaning is more specific than "Adenosine Monophosphate".
This graph shows the total number of publications written about "Adenosine Monophosphate" by people in this website by year, and whether "Adenosine Monophosphate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 0 | 1 | 1 | | 1998 | 1 | 2 | 3 | | 2001 | 0 | 2 | 2 | | 2002 | 1 | 1 | 2 | | 2003 | 2 | 0 | 2 | | 2006 | 0 | 1 | 1 | | 2007 | 1 | 2 | 3 | | 2011 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2016 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 1 | 2 | | 2021 | 4 | 5 | 9 | | 2022 | 1 | 3 | 4 | | 2023 | 0 | 4 | 4 | | 2024 | 5 | 0 | 5 | | 2025 | 3 | 0 | 3 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenosine Monophosphate" by people in Profiles.
-
Baker JV, Siegel LK, Losso MH, Vasudeva S, Nordwall JA, Harper K, Grund B, Havens JP, Fletcher CV, Fishchuk R, Kobrynska O, Abutidze A, Metchurtchlishvili R, Ginde AA, Aggarwal NR, Poulakou G, Mourad A, Gibbs KW, Saito S, Chayakulkeeree M, Mootsikapun P, Honda H, Mateu L, Gyrina O, Garcia A, Lee DG, Casey JD, Jain MK, Bengtson CD, Hite RD, Hiranburana N, Matthay MA, Arizmendez N, Nguyen HH, Drelick A, Mena Lora AJ, Parnia S, Trautner BW, Portsmouth SD, Shimizu R, Uehara T, Paredes R, Goodman AL, Vock DM, Gelijns AC, Weintrob AC, Bajema KL, Pett SL, Lundgren J, Schechner AJ, Higgs ES, Lane HC, Matthews GV, Self WH, Reilly C. Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial. Clin Infect Dis. 2026 Jul 23; 83(1):59-69.
-
Gargiulo G, Narciso V, Forzano I, Sperandeo L, Castiello DS, Simonetti F, Manzi L, Florimonte D, Canonico ME, Avvedimento M, Paolillo R, Spinelli A, Di Serafino L, Spaccarotella CAM, Franzone A, Piccolo R, Stabile E, Cirillo P, Valgimigli M, Esposito G. Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study. Eur Heart J Acute Cardiovasc Care. 2026 Jul 08; 15(7):524-534.
-
Agarwal T, Beaty LE, Carlson NE, Bennett TD, Fish LE, Mayer DA, Molina KC, Peers JL, Webb BJ, Xiao M, Ginde AA, Aggarwal NR. Association of remdesivir treatment with long-term mortality after COVID-19 hospitalization. BMC Infect Dis. 2025 Oct 28; 25(1):1418.
-
Pentyala A, Kandel SE, Lampe JN. Mechanistic insights into human carboxylesterase 2 (CES2) inhibition by the CES1 prodrug substrate remdesivir. Drug Metab Dispos. 2025 Oct; 53(10):100158.
-
Gargiulo G, Cirillo P, Sperandeo L, Castiello DS, Manzi L, Forzano I, Florimonte D, Simonetti F, Canonico ME, Avvedimento M, Paolillo R, Spinelli A, Buongiorno F, Serafino LD, Spaccarotella CAM, Franzone A, Piccolo R, Stabile E, Valgimigli M, Esposito G. Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry. EuroIntervention. 2025 May 16; 21(10):560-570.
-
Brooks KM, Baltrusaitis K, Clarke DF, Nachman S, Jao J, Purswani MU, Agwu A, Beneri C, Deville JG, Powis KM, Stek AM, Eke AC, Shapiro DE, Capparelli E, Greene E, George K, Yin DE, Jean-Philippe P, Chakhtoura N, Bone F, Bacon K, Johnston B, Reding C, Kersey K, Humeniuk R, Best BM, Mirochnick M, Momper JD. Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032. J Infect Dis. 2024 Oct 16; 230(4):878-888.
-
Molina KC, Webb BJ, Kennerley V, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Aggarwal NR, Ginde AA. Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5. BMC Infect Dis. 2024 Aug 08; 24(1):802.
-
Bulluck H, Chong JH, Bryant J, Annathurai A, Chai P, Chan M, Chawla A, Chin CY, Chung YC, Gao F, Ho HH, Ho AFW, Hoe J, Imran SS, Lee CH, Lim B, Lim ST, Lim SH, Liew BW, Zhan Yun PL, Ong MEH, Paradies V, Pung XM, Tay JCK, Teo L, Ting BP, Wong A, Wong E, Watson T, Chan MY, Keong YK, Tan JWC, Hausenloy DJ. Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial). Circulation. 2024 Jul 09; 150(2):91-101.
-
Bertrand K, Sepulveda Y, Spiegel BJ, Best BM, Suhandynata R, Rossi S, Chambers CD, Momper JD. Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19. Pediatr Res. 2024 Jul; 96(2):269-272.
-
Schimmel J, Epperson LC, Aldy K, Wax P, Brent J, Buchanan J, Levine M, Burkhart K. Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. Drugs. 2024 Feb; 84(2):209-217.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|